- Title: Subtitle
- Reply to Wen-Wei Sung’s Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011
- Creators
- Wei Shen Tan - The University of Texas MD Anderson Cancer CenterMichael O'Donnell - University of IowaRoger Li - Moffitt Cancer CenterAshish M. Kamat - The University of Texas MD Anderson Cancer CenterVignesh T. Packiam - Rutgers, The State University of New Jersey
- Resource Type
- Letter/Communication
- Publication Details
- European urology oncology
- Publisher
- Elsevier B.V
- DOI
- 10.1016/j.euo.2023.10.009
- ISSN
- 2588-9311
- eISSN
- 2588-9311
- Language
- English
- Date published
- 10/2023
- Academic Unit
- Urology
- Record Identifier
- 9984502957602771
Letter/Communication
Reply to Wen-Wei Sung’s Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non–muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011
European urology oncology
10/2023
DOI: 10.1016/j.euo.2023.10.009
Details
Metrics
1 Record Views